Private sleuths take time referring fraud cases to Medicare

NewsGuard 100/100 Score
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution]. By that time, many cases go cold ... A recent inspector general report also raised questions about the contractors, who play an important role in Medicare's overall effort to combat fraud. Out of $835 million in questionable Medicare payments identified by private contractors in 2007, the government was only able to recover some $55 million," while Medicare overpayments "totaled more than $36 billion in 2009, according to the Obama administration" (Zaldivar, 8/8).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
KFF Health News' 'What the Health?': Biden wins early court test for Medicare drug negotiations